Publications by authors named "Arabella Stuart"

Claim this Profile
D
Development of a live-attenuated vaccine challenge model of Yersinia pestis in humans: Expert consultation on clinical trial considerations, January 2025.
Anna Rydlova, Emma Smith, Arabella Stuart, Robin Shattock, Tim Brooks

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study.
Shuo Feng, Sagida Bibi, Parvinder K Aley, Federica Cappuccini, Elizabeth A Clutterbuck, Arabella Stuart

J Infect· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trial.
Maia Patrick-Smith, Katherine Emary, Susanne H Hodgson, Tonia M Thomas, Rebecca Te Water Naude, Arabella S V Stuart

Vaccine· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines.
Tonia M Thomas, Susanne H Hodgson, Katherine Emary, Maia Patrick-Smith, Rebecca Te Water Naude, Arabella S V Stuart

Hum Vaccin Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-producing Human and Animal Experimental Subjects: Exploring the Views of UK COVID-19 Vaccine Trial Participants on Animal Testing.
Samantha Vanderslott, Alexandra Palmer, Tonia Thomas, Beth Greenhough, Arabella Stuart

Sci Technol Human Values· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
Robert H Shaw, Melanie Greenland, Arabella S V Stuart, Parvinder K Aley, Nick J Andrews

J Infect· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months.
Arabella S V Stuart, Miia Virta, Kristi Williams, Ilkka Seppa, Robyn Hartvickson

J Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.
Robert H Shaw, Xinxue Liu, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley

Lancet Respir Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Arabella S V Stuart, Robert H Shaw, Xinxue Liu, Melanie Greenland, Parvinder K Aley

Lancet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
Wanwisa Dejnirattisai, Robert H Shaw, Piyada Supasa, Chang Liu, Arabella Sv Stuart, Dave I Stuart

Lancet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom.
Samantha Vanderslott, Katherine Emary, Rebecca Te Water Naude, Marcus English, Tonia Thomas, Arabella Stuart

BMJ Glob Health· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Xinxue Liu, Robert H Shaw, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley

Lancet· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
Robert H Shaw, Arabella Stuart, Melanie Greenland, Xinxue Liu, Jonathan S Nguyen Van-Tam

Lancet· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge and experience of a cohort of HIV-positive and HIV-negative Ghanaian women after undergoing human papillomavirus and cervical cancer screening.
Arabella Stuart, Dorcas Obiri-Yeboah, Yaw Adu-Sarkodie, Anna Hayfron-Benjamin, Angela D Akorsu

BMC Womens Health· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of strategies to recruit and retain primary care doctors.
Puja Verma, John A Ford, Arabella Stuart, Amanda Howe, Sam Everington

BMC Health Serv Res· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-VEGF therapies in the treatment of choroidal neovascularisation secondary to non-age-related macular degeneration: a systematic review.
Arabella Stuart, John A Ford, Susan Duckworth, Colin Jones, Augustine Pereira

BMJ Open· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis